当前位置: X-MOL 学术Clin. Infect. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
National Healthcare Safety Network Standardized Antimicrobial Administration Ratios (SAARs): A Progress Report and Risk Modeling Update Using 2017 Data
Clinical Infectious Diseases ( IF 11.8 ) Pub Date : 2020-03-26 , DOI: 10.1093/cid/ciaa326
Erin N O'Leary 1, 2 , Jonathan R Edwards 1 , Arjun Srinivasan 1 , Melinda M Neuhauser 1 , Amy K Webb 1, 2 , Minn M Soe 1 , Lauri A Hicks 1 , Wendy Wise 1, 2 , Hsiu Wu 1 , Daniel A Pollock 1
Affiliation  

The Standardized Antimicrobial Administration Ratio (SAAR) is a risk-adjusted metric of antimicrobial use (AU) developed by the Centers for Disease Control and Prevention (CDC) in 2015 as a tool for hospital antimicrobial stewardship programs (ASPs) to track and compare AU with a national benchmark. In 2018, CDC updated the SAAR by expanding the locations and antimicrobial categories for which SAARs can be calculated and by modeling adult and pediatric locations separately.

中文翻译:

国家医疗安全网络标准化抗菌药物管理比率(SAAR):使用2017年数据进行的进度报告和风险建模更新

标准化抗菌药物管理比率(SAAR)是由疾病控制与预防中心(CDC)于2015年开发的一种风险调整后的抗菌药物使用量(AU),作为医院抗菌药物管理计划(ASPs)跟踪和比较AU的工具具有国家基准。在2018年,疾病预防控制中心通过扩展可计算SAAR的位置和抗菌类别以及分别对成人和儿科位置进行建模来更新SAAR。
更新日期:2020-03-26
down
wechat
bug